News

Purpose Large bore catheters are increasingly used in mechanical thrombectomy (MT) for large vessel occlusions (LVOs). Objective To evaluate the efficacy and safety of the super-large bore Cereglide 0 ...
Background Flow diverters have revolutionized the treatment of intracranial aneurysms. However, the delayed complications associated with flow diverter use are unknown. Objective To evaluate the ...
Correspondence to Dr Bart J Emmer, Department of Radiology, Amsterdam University Medical Centres, Amsterdam, Netherlands; b.j.emmer{at}amsterdamumc.nl Background Endovascular treatment (EVT) is ...
Background Whether pretreatment with intravenous thrombolysis prior to mechanical thrombectomy (IVT+MTE) adds additional benefit over direct mechanical thrombectomy (dMTE) in patients with large ...
Correspondence to Dr Athos Patsalides, Division of Interventional Neuroradiology, Department of Neurological Surgery, Weill Cornell Medine, New York, NY 10065, USA; atp9002{at}med.cornell.edu Aims We ...
Correspondence to Dr Anna Andriana Kyselyova, Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany; a.kyselyova{at}uke.de ...
2 Department of Interventional Neuroradiology, Careggi University Hospital, Florence, Italy 3 Department of Interventional Radiology and Neuroradiology, ‘Santo Spirito’ Hospital, Pescara, Italy ...
Correspondence to Dr Justin F Fraser, Neurological Surgery, University of Kentucky, Lexington, KY 40536, USA; Jfr235{at}uky.edu ...
Correspondence to Mr Noel van Horn, Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg Eppendorf, Hamburg, Hamburg, Germany; no.vanhorn{at}uke.de Background ...
Correspondence to Nicole Mariantonia Cancelliere, Division of Neuroradiology, Department of Medical Imaging, Toronto Western Hospital, Toronto, ON M5T 2S8, Canada; nicole.cancelliere{at}unityhealth.to ...
Correspondence to Dr Raul G Nogueira, Marcus Stroke & Neuroscience Center, Grady Memorial Hospita, Emory University School of Medicine, Atlanta, GA 30303, USA; raul.g.nogueira{at}emory.edu Background ...
Background Malignant gliomas continue to have a poor clinical outcome with available therapies. In the past few years, new targeted biologic therapies have been studied, with promising results.